Ignite Creation Date:
2025-12-25 @ 4:24 AM
Ignite Modification Date:
2025-12-26 @ 3:27 AM
Study NCT ID:
NCT07241520
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-21
First Post:
2025-11-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke
Sponsor:
Shanghai Hutchison Pharmaceuticals Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-17
First Submit QC Date:
None
Study First Post Date:
2025-11-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED